J
Joel S. Krasnow
Researcher at University of Pittsburgh
Publications - 17
Citations - 3856
Joel S. Krasnow is an academic researcher from University of Pittsburgh. The author has contributed to research in topics: Zoledronic acid & Bone remodeling. The author has an hindex of 13, co-authored 17 publications receiving 3672 citations. Previous affiliations of Joel S. Krasnow include Novartis.
Papers
More filters
Journal ArticleDOI
Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis
Dennis M. Black,Pierre D. Delmas,Richard Eastell,Ian R. Reid,Steven Boonen,Jane A. Cauley,Felicia Cosman,Peter L. Lakatos,Ping Chung Leung,Z. Man,Carlos Mautalen,Peter Mesenbrink,Huilin Hu,John Caminis,Karen Tong,Theresa Rosario-Jansen,Joel S. Krasnow,Trisha F. Hue,Deborah E. Sellmeyer,Erik Fink Eriksen,Steven R. Cummings +20 more
TL;DR: Treatment with zoledronic acid reduced the risk of morphometric vertebral fracture by 70% during a 3-year period, as compared with placebo.
Journal ArticleDOI
Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis
Dennis M. Black,Pierre D. Delmas,Richard Eastell,Ian R. Reid,Steven Boonen,Jane A. Cauley,Felicia Cosman,Peter L. Lakatos,Ping-Chung Leung,Z. Man,Carlos Mautallen,Peter Mesenbrink,Huilin Hu,John Caminis,Karen Tong,Theresa Rosario-Jansen,Joel S. Krasnow,Trisha F. Hue,Deborah E. Sellmeyer,Erik Fink Eriksen,Steven R. Cummings +20 more
TL;DR: A once-yearly infusion of zoledronic acid during a 3-year period significantly reduced the risk of vertebral, hip, and other fractures and was associated with a significant improvement in bone mineral density and bone metabolism markers.
Journal ArticleDOI
Ovarian responses in women to recombinant follicle-stimulating hormone and luteinizing hormone (LH): a role for LH in the final stages of follicular maturation.
TL;DR: It is indicated that once FSH initiates follicular growth, either FSH or LH is capable of sustaining follicular estradiol production.
Journal ArticleDOI
Regional specialization of the cell membrane-associated, polymorphic mucin (MUC1) in human uterine epithelia.
TL;DR: It is demonstrated that MUC1 expression in the luminal epithelium is maintained throughout the menstrual cycle, and observations suggest that regionally restricted glycosylation generates an altered external structure of M UC1.
Journal ArticleDOI
Implantation and early pregnancy: Endometrial Th2 cytokine expression throughout the menstrual cycle and early pregnancy
TL;DR: During pregnancy, Th2 expression paralleled that of vimentin, a stromal cell marker, suggesting that these cells may be a principal source of these cytokines in the gravid uterus.